CinCor Pharma (CINC) Short Interest Ratio & Short Volume

Short interest is the volume of CinCor Pharma shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 338,600 shares of CINC short. 2.00% of CinCor Pharma's shares are currently sold short. Learn More on CinCor Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CINC shares currently have a short interest ratio of 1.0. Learn More on CinCor Pharma's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CinCor Pharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.00% of CinCor Pharma's floating shares are currently sold short.

CinCor Pharma saw a drop in short interest in the month of January. As of January 31st, there was short interest totaling 338,600 shares, a drop of 74.7% from the previous total of 1,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

CinCor Pharma currently has issued a total of 43,760,000 shares. Some of CinCor Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. CinCor Pharma currently has a public float of 16,960,000 shares.

2.00% of CinCor Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to CinCor Pharma: Day One Biopharmaceuticals, Inc. (15.24%), Pacira BioSciences, Inc. (8.04%), Ironwood Pharmaceuticals, Inc. (14.48%), Kiniksa Pharmaceuticals, Ltd. (4.55%), Deciphera Pharmaceuticals, Inc. (12.26%), AbCellera Biologics Inc. (11.50%), Gyre Therapeutics, Inc. (0.87%), ANI Pharmaceuticals, Inc. (0.93%), Collegium Pharmaceutical, Inc. (23.28%), Ocular Therapeutix, Inc. (7.95%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.19 billion), Snowflake Inc. ($2.35 billion), T. Rowe Price Group, Inc. ($2.14 billion), Coinbase Global, Inc. ($2.14 billion), Paramount Global ($1.99 billion), Etsy, Inc. ($1.76 billion), Lucid Group, Inc. ($1.70 billion), Wayfair Inc. ($1.63 billion), Old Dominion Freight Line, Inc. ($1.61 billion), and CarMax, Inc. ($1.60 billion). View all of the most shorted stocks.

Short selling CINC is an investing strategy that aims to generate trading profit from CinCor Pharma as its price is falling. CINC shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for CinCor Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CINC, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CINC, twice per month. The most recent reporting period available is January, 31 2023.